Literature DB >> 18848512

Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.

Tiphaine Legrand1, Stéphanie Chhun, Elisabeth Rey, Benoît Blanchet, Jean-Ralph Zahar, Fanny Lanternier, Gérard Pons, Vincent Jullien.   

Abstract

A simple, precise and accurate high-performance liquid chromatography (HPLC) method using ultraviolet (UV) detection has been developed for simultaneous determination of carbapenem antibiotics: imipenem, meropenem and ertapenem in human plasma. Samples were spiked with ceftazidime as internal standard and proteins were precipitated by acetonitrile. Separation was achieved on a C8 column with a mobile phase composed of phosphate buffer 0.1M (pH 6.8) and methanol in gradient elution mode. Detection was performed at 298 nm. Calibration curves were linear from 0.5 to 80 mg/L for each compound, with correlation coefficients over 0.997. Intra- and inter-day validation studies showed accuracy between -4.5 and 8.1% and precision below 10.4%. Mean recoveries were 82.2, 90.8 and 87.7% for imipenem, meropenem and ertapenem, respectively. This method provides a useful tool for the therapeutic drug monitoring of carbapenems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848512     DOI: 10.1016/j.jchromb.2008.09.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  12 in total

1.  Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.

Authors:  Marie-Clémence Verdier; Olivier Tribut; Pierre Tattevin; Yves Le Tulzo; Christian Michelet; Danièle Bentué-Ferrer
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe; Anna Marchese; Andrea Parisini; Carmen Fucile; Erika Coppo; Valeria Marini; Antonio Arena; Alexandre Molin; Antonietta Martelli; Angelo Gratarola; Claudio Viscoli; Paolo Pelosi; Francesca Mattioli
Journal:  Virulence       Date:  2016-07-18       Impact factor: 5.882

3.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

4.  Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.

Authors:  Joan Antoni Schoenenberger-Arnaiz; Faten Ahmad-Diaz; Mar Miralbes-Torner; Ana Aragones-Eroles; Manuel Cano-Marron; Mercedes Palomar-Martinez
Journal:  Eur J Hosp Pharm       Date:  2019-02-27

5.  Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS.

Authors:  David R Peaper; Mandar V Kulkarni; Alexandra N Tichy; Michael Jarvis; Thomas S Murray; Michael E Hodsdon
Journal:  Bioanalysis       Date:  2013-01       Impact factor: 2.681

6.  Nonvolatile salt-free stabilizer for the quantification of polar imipenem and cilastatin in human plasma using hydrophilic interaction chromatography/quadrupole mass spectrometry with contamination sensitive off-axis electrospray.

Authors:  Zhe-Yi Hu; Bradley A Boucher; S Casey Laizure; Vanessa L Herring; Robert B Parker; William L Hickerson
Journal:  J Mass Spectrom       Date:  2013-08       Impact factor: 1.982

7.  Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.

Authors:  Francesca Mattioli; Carmen Fucile; Valerio Del Bono; Valeria Marini; Andrea Parisini; Alexandre Molin; Maria Laura Zuccoli; Giulia Milano; Romano Danesi; Anna Marchese; Marialuisa Polillo; Claudio Viscoli; Paolo Pelosi; Antonietta Martelli; Antonello Di Paolo
Journal:  Eur J Clin Pharmacol       Date:  2016-04-06       Impact factor: 2.953

8.  Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study.

Authors:  Aiping Wen; Zhe Li; Junxian Yu; Ren Li; Sheng Cheng; Meili Duan; Jing Bai
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

9.  Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate.

Authors:  Femke de Velde; Brenda C M de Winter; Michael N Neely; Walter M Yamada; Birgit C P Koch; Stephan Harbarth; Elodie von Dach; Teun van Gelder; Angela Huttner; Johan W Mouton
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

10.  Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients.

Authors:  Femke de Velde; Brenda C M de Winter; Michael N Neely; Jan Strojil; Walter M Yamada; Stephan Harbarth; Angela Huttner; Teun van Gelder; Birgit C P Koch; Anouk E Muller
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.